Beyond Motor Neuron Degeneration: Non-Motor Manifestations and Multisystem Involvement in Amyotrophic Lateral Sclerosis
4 affiliations
- 1Neurology Clinic, Colentina Clinical Hospital, 020125 Bucharest, Romania
- 2Doctoral School, “George Emil Palade” University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania
- 3Emergency Institute for Cardiovascular Diseases “Prof. Dr. C.C. Iliescu”, 022322 Bucharest, Romania
- 4Department of Neurology, “George Emil Palade” University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that primarily affects the motor system through the degeneration of motor neurons in the motor cortex, brainstem nuclei, and anterior horn of the spinal cord. ALS typically has a focal onset characterized by muscle weakness, followed by progressive spreading to other body regions, with respiratory muscle failure representing the main life-limiting complication. Median survival is approximately 2–5 years after disease onset. In addition to the well-established motor manifestations, non-motor symptoms are increasingly recognized and may occur in approximately 50% of patients. These include behavioral and neuropsychiatric disturbances, sleep disorders, sensory abnormalities, autonomic dysfunction involving the cardiovascular, gastrointestinal, and genitourinary systems, as well as metabolic and endocrine alterations. Recent evidence supports the concept of ALS as a multisystem disorder characterized by substantial clinical, genetic, and neuropathological heterogeneity. Nevertheless, non-motor manifestations remain less extensively characterized than motor symptoms and are frequently underestimated in clinical practice. This narrative review summarizes the current evidence on non-motor manifestations in ALS, discusses their potential underlying mechanisms and impact on quality of life, and highlights areas requiring further investigation. A better understanding and systematic assessment of these manifestations may contribute to a more comprehensive and patient-centered approach to ALS care.
Related
- Systemic Sclerosis Presenting With Long-Standing Peripheral Neuropathy and Delayed Multisystem Manifestations: A Case Report
- A genetic screen for suppressors of neuron degeneration in a C. elegans sod-1G85R model of Amyotrophic Lateral Sclerosis
- Transient Post-infectious Multisystem Inflammatory Overlap Presentation in a Pediatric Patient With Neurological, Hepatic, Gastrointestinal, and Autoimmune Manifestations: A Rare Case From Azerbaijan
- Transcutaneous Carbon Dioxide Monitoring in Amyotrophic Lateral Sclerosis: A Scoping Review
- The value of a family history to distinguish monogenic from polygenic amyotrophic lateral sclerosis
BibTeX
@article{veciunca2026beyond,
title = {{Beyond Motor Neuron Degeneration: Non-Motor Manifestations and Multisystem Involvement in Amyotrophic Lateral Sclerosis}},
author = {Maria Veciunca and Medeea Roman and Vlăduț-Gabriel Vasiliu and Rodica Bălașa and Anca Moțățăianu},
journal = {Journal of Clinical Medicine},
year = {2026},
month = nov,
doi = {10.3390/jcm15218750},
url = {https://www.mdpi.com/2077-0383/15/21/8750},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Beyond Motor Neuron Degeneration: Non-Motor Manifestations and Multisystem Involvement in Amyotrophic Lateral Sclerosis
AU - Maria Veciunca
AU - Medeea Roman
AU - Vlăduț-Gabriel Vasiliu
AU - Rodica Bălașa
AU - Anca Moțățăianu
PY - 2026
DA - 2026/11/09
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218750
UR - https://www.mdpi.com/2077-0383/15/21/8750
AB - Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that primarily affects the motor system through the degeneration of motor neurons in the motor cortex, brainstem nuclei, and anterior horn of the spinal cord. ALS typically has a focal onset characterized by muscle weakness, followed by progressive spreading to other body regions, with respiratory muscle failure representing the main life-limiting complication. Median survival is approximately 2–5 years after disease onset. In addition to the well-established motor manifestations, non-motor symptoms are increasingly recognized and may occur in approximately 50% of patients. These include behavioral and neuropsychiatric disturbances, sleep disorders, sensory abnormalities, autonomic dysfunction involving the cardiovascular, gastrointestinal, and genitourinary systems, as well as metabolic and endocrine alterations. Recent evidence supports the concept of ALS as a multisystem disorder characterized by substantial clinical, genetic, and neuropathological heterogeneity. Nevertheless, non-motor manifestations remain less extensively characterized than motor symptoms and are frequently underestimated in clinical practice. This narrative review summarizes the current evidence on non-motor manifestations in ALS, discusses their potential underlying mechanisms and impact on quality of life, and highlights areas requiring further investigation. A better understanding and systematic assessment of these manifestations may contribute to a more comprehensive and patient-centered approach to ALS care.
SN - 2077-0383
ER -